William McDowall Wells

This profile gathers the share dealings of William McDowall Wells across 2 companies, led by Acadia Pharmaceuticals Inc and Valeant Pharmaceuticals International, Inc. Between 5 October 2010 and 21 November 2014, the trades on record add up to 18 filings.

Sales make up the whole of the open-market record (8 sales, €18.9M). Outside the open market, there are 2 share grants and 8 option exercises. In 2014 alone, the filings show no purchases and 5 sales.

The newest entry dates from 21 November 2014: an option exercise of €6,299, in Acadia Pharmaceuticals Inc. Typically, a trade is published a median of 2 days after it takes place. The shorter that gap, the sooner other investors can see what insiders have done. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.